These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19871681)

  • 1. PLASMA ESTERASE ACTIVITY IN PATIENTS WITH LIVER DISEASE AND THE NEPHROTIC SYNDROME.
    Kunkel HG; Ward SM
    J Exp Med; 1947 Sep; 86(4):325-37. PubMed ID: 19871681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [State of the kinin system and level of serum proteinase inhibitors in latent nephritis and the nephrotic syndrome of different etiology].
    Paskhina TS; Poliantseva LR; Krinskaia AV; Belolipetskaia IuG; Nartikova VF
    Vopr Med Khim; 1977; 23(2):241-51. PubMed ID: 70111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications.
    Ackerman Z
    J Clin Gastroenterol; 1996 Jan; 22(1):31-4. PubMed ID: 8776092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fructosamine concentration in patients with nephrotic syndrome and with cirrhosis of the liver: the influence of hypoalbuminaemia and hypergammaglobulinaemia.
    Constanti C; Simo JM; Joven J; Camps J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():437-42. PubMed ID: 1642452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes.
    de Sain-van der Velden MG; Kaysen GA; de Meer K; Stellaard F; Voorbij HA; Reijngoud DJ; Rabelink TJ; Koomans HA
    Kidney Int; 1998 Jan; 53(1):181-8. PubMed ID: 9453016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R; Jaubert F; Leon M; Bellon B; Aiach M; Josso F; Lepelletier O; Beguin S; Monnet JP
    Thromb Haemost; 1983 Feb; 49(1):13-7. PubMed ID: 6601862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma composition in the nephrotic syndrome.
    Kaysen GA
    Am J Nephrol; 1993; 13(5):347-59. PubMed ID: 8116687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for the estimation of esterase synthesis and degradation and its application to evaluate the influence of insulin and glucagon.
    Heymann E; Mentlein R; Schmalz R; Schwabe C; Wagenmann F
    Eur J Biochem; 1979 Dec; 102(2):509-19. PubMed ID: 393510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAMe esterase activity in human plasma under normal and pathological conditions.
    Kumagai N; Abe K; Mouri T; Seki T; Yoshinaga K
    Tohoku J Exp Med; 1968 Jun; 95(2):121-6. PubMed ID: 5723201
    [No Abstract]   [Full Text] [Related]  

  • 16. Albumin metabolism in the nephrotic syndrome: the effect of dietary protein intake.
    Kaysen GA
    Am J Kidney Dis; 1988 Dec; 12(6):461-80. PubMed ID: 3057880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
    Zoccali C; Mallamaci F; Panuccio V; Tripepi G; Cutrupi S; Parlongo S; Catalano F; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
    Kidney Int Suppl; 2003 May; (84):S98-102. PubMed ID: 12694320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonally sensitive esterase activity in the mouse uterus results from uptake of plasma esterase.
    Kadner SS; Katz J; Berliner BA; Levitz M; Finlay TH
    Endocrinology; 1984 Dec; 115(6):2406-17. PubMed ID: 6499775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma IgG pool is not defended from urinary loss in nephrotic syndrome.
    al-Bander HA; Martin VI; Kaysen GA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):F333-7. PubMed ID: 1558152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome.
    Machleidt C; Mettang T; Stärz E; Weber J; Risler T; Kuhlmann U
    Kidney Int; 1989 Dec; 36(6):1119-24. PubMed ID: 2532267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.